- Gastrointestinal hormones and gut motility
Theo L. Peeters, 2015, Current Opinion in Endocrinology & Diabetes and Obesity CrossRef - Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome
Mahanand Chatoo et al, 2018, Frontiers in Endocrinology CrossRef - Risk factors for irritable bowel syndrome: A review
Olga V. Gaus et al, 2024, Terapevticheskii arkhiv CrossRef - Preclinical models of irritable bowel syndrome
Laura López-Gómez et al, 2020, A Comprehensive Overview of Irritable Bowel Syndrome CrossRef - Proteomics and irritable bowel syndrome
Athanasios Tsigaridas et al, 2017, Expert Review of Proteomics CrossRef - Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants
Jessica M. Lee et al, 2018, Journal of Lipid Research CrossRef - Bile acid malabsorption is associated with diarrhea in acute phase of colitis
Rui-gang Hou et al, 2018, Canadian Journal of Physiology and Pharmacology CrossRef - Effects of Fengliao-Changweikang in Diarrhea-predominant Irritable Bowel Syndrome Rats and Its Mechanism Involving Colonic Motility
Mengdi Jia et al, 2018, Journal of Neurogastroenterology and Motility CrossRef - Physical activity in relation to irritable bowel syndrome among Iranian adults
Mehdi Sadeghian et al, 2018, PLOS ONE CrossRef - Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome
Zheng-Yang Li et al, 2024, World Journal of Gastroenterology CrossRef - PI 3‐kinase‐ and ERK‐MAPK‐dependent mechanisms underlie Glucagon‐Like Peptide‐1‐mediated activation of Sprague Dawley colonic myenteric neurons
Rebecca O'Brien et al, 2019, Neurogastroenterology & Motility CrossRef - Colorectal sensation and motility
Vineet S. Gudsoorkar et al, 2014, Current Opinion in Gastroenterology CrossRef - Endocrine regulation of gut function – a role for glucagon‐like peptide‐1 in the pathophysiology of irritable bowel syndrome
Dervla O'Malley, 2019, Experimental Physiology CrossRef - Early life adverse exposures in irritable bowel syndrome: new insights and opportunities
Guo Qiong Zhou et al, 2023, Frontiers in Pediatrics CrossRef - The Glucagon‐like peptide‐1 receptor agonist, exendin‐4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome
Rebecca O’Brien et al, 2020, Neurogastroenterology & Motility CrossRef - Glucagon‑like peptide‑1 analogue exendin‑4 modulates serotonin transporter expression in intestinal epithelial cells
Xiufang Cui et al, 2020, Molecular Medicine Reports CrossRef